Table 1.
Demographic and clinical measures across subject groups
| Measures | HC
(N = 26) |
T2DM
(N = 20) |
Statistics |
||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | F | df | P | |
| Age (years) | 62.92 | 12.71 | 65.05 | 11.95 | 0.333 | 1, 44 | 0.567 |
| Sex (n) | 11 M, 15 F | 12 M, 8 F | χ2 = 1.415 | 1 | 0.234 | ||
| Race (n) | 10 B, 2 H, 1 A, 11 W, 2 O | 11 B, 1 H, 0 A, 8 W, 0 O | χ2 = 3.125 | 4 | 0.537 | ||
| Handedness (n) | 25 R, 1 L, 0 M | 16 R, 3 L, 1 M | χ2 = 3.248 | 2 | 0.197 | ||
| Education (years) | 14.54 | 1.86 | 14.80 | 2.28 | 0.184 | 1, 44 | 0.670 |
| WTAR | 102.52 | 11.09 | 99.95 | 16.54 | 0.387 | 1, 43a | 0.537 |
| MMSE | 28.92 | 0.98 | 28.35 | 1.18 | 3.241 | 1, 44 | 0.079 |
| HAM-D | 0.96 | 1.311 | 1.65 | 1.843 | 2.193 | 1, 44 | 0.146 |
| BMI (kg/m2) | 30.18 | 17.54 | 31.43 | 5.91 | 0.092 | 1, 44 | 0.763 |
| SBP (mmHg) | 136.38 | 14.05 | 139.30 | 17.87 | 0.384 | 1, 44 | 0.539 |
| DBP (mmHg) | 79.85 | 10.06 | 83.70 | 10.30 | 1.627 | 1, 44 | 0.209 |
| T2DM duration (months) | — | — | 115.15 | 85.19 | — | — | — |
| HDL cholesterol | 72.88 | 22.21 | 48.15 | 13.27 | 19.406 | 1, 44 | <0.001 |
| LDL cholesterol | 93.27 | 23.99 | 88.00 | 22.56 | 0.574 | 1, 44 | 0.453 |
| CIRS | 3.69 | 2.83 | 7.15 | 3.05 | 15.812 | 1, 44 | <0.001 |
| FSRP | 8.81 | 4.61 | 13.00 | 4.90 | 8.848 | 1, 44 | 0.005 |
| mFSRP (T2DM removed) | 8.81 | 4.61 | 10.60 | 5.14 | 1.544 | 1, 44 | 0.221 |
| HbA1c (%) (mmol/mol) | 5.70 (39) | 0.36 (3.9) | 7.37 (57) | 1.67 (18.3) | 24.503 | 1, 44 | <0.001 |
A, Asian; B, black; F, female; H, Hispanic; L, left; M (handedness), mixed; M (sex), male; O, other; R, right; W, white.
aOne control subject’s WTAR was not recorded. Measures with significant group differences are in boldface text.